He was for over 10 years an Associate Director of the National Cancer Research Network since its inception in 2001, an organisation which more than doubled the number of patients going into cancer studies in England.

Max joined the MRC in 1987. He has more than 500 publications in peer reviewed journals, many of which have had direct impact on policy, clinical practice and improving outcomes for patients. The Unit he directs is at the forefront of resolving internationally important questions, particularly in infectious diseases, cancer and neurodegenerative diseases and also has developed methods to deliver swifter and more effective translation of scientific research into patient benefits.

It does this by carrying out challenging and innovative studies, particularly by developing and implementing methodological advances in study design, conduct and analysis.